Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2008 Feb 28;43:137–159. doi: 10.1016/S0091-679X(08)60602-0

Chapter 7 Use of Recombinant Vaccinia Virus Vectors for Cell Biology

Ora A Weisz 1, Carolyn E Machamer 1
PMCID: PMC7130382  PMID: 7823860

Publisher Summary

This chapter describes the use of several of the recombinant vaccinia expression systems, focuses on the systems that are most useful for cell biologists, and discusses their advantages and limitations. Vaccinia-mediated expression can be used for assessing cellular localization, posttranslational modifications, oligomerization, and transport and turnover rates. The system provides a rapid method for screening mutant proteins for expression and targeting. It is an excellent way of quickly deciding which mutant proteins might be worth further studying using stable expression systems. Expression of foreign genes using Vaccinia virus is based on recombinant viruses constructed by insertion of complementary DNA (cDNA) into the nonessential thymidine kinase (TK) gene. Both direct and indirect methods of expression are possible. The foreign gene can be inserted into the vaccinia genome by homologous recombination using a plasmid with flanking regions of vaccinia DNA. The recombinant virus is selected, expanded, and used to infect cells, which then express high levels of the foreign protein. Recombinant vaccinia viruses are generated by subcloning the foreign gene into a plasmid transfer vector so it is flanked by DNA from the vaccinia (TK) gene, which is nonessential for growth of the virus in tissue culture. This plasmid is then transfected into vaccinia-infected cells. Homologous recombination of the plasmid and the vaccinia genome generates a recombinant virus with an inactive TK gene.

References

  1. Chakrabarti S., Brechling K., Moss B. Vaccinia virus expression vector: Coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 1985;5:3403–3409. doi: 10.1128/mcb.5.12.3403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Doms R.W., Blumenthal R., Moss B. Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane. J. Virol. 1990;64:4884–4892. doi: 10.1128/jvi.64.10.4884-4892.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Earl P.L., Moss B. Generation of recombinant vaccinia viruses. In: Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Struhl K., editors. Greene Publishing Associates and Wiley Interscience; New York: 1991. pp. 16–17.1--16.17.16. (“Current Protocols in Molecular Biology”). [Google Scholar]
  4. Elroy-Stein O., Fuerst T.R., Moss B. Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5′ sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system. Proc. Natl. Acad. Sci. USA. 1989;86:6126–6130. doi: 10.1073/pnas.86.16.6126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fuerst T.R., Niles E.G., Studier W., Moss B. Eukaryotic transient-expressions system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA. 1986;83:8122–8126. doi: 10.1073/pnas.83.21.8122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Goebel S.J., Johnson G.P., Perkus M.E., Davis S.W., Winslow J.P., Paoletti E. The complete DNA sequence of vaccinia virus. Virology. 1990;179:247–266. doi: 10.1016/0042-6822(90)90294-2. [DOI] [PubMed] [Google Scholar]
  7. Griffiths G., Rottier P. Cell biology of viruses that assemble along the biosynthetic pathway. Sem. Cell Biol. 1992;3:367–381. doi: 10.1016/1043-4682(92)90022-N. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Grist N.R. Smallpox vaccination for investigators. Lancet. 1989;ii:919. [PubMed] [Google Scholar]
  9. Krijnse Locker J., Griffiths G., Horzinek M.C., Rottier P.J.M. O-glycosylation of the coronavirus M protein. J. Biol. Chem. 1992;267:14094–14101. doi: 10.1016/S0021-9258(19)49683-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Machamer C.E., Rose J.K. A specific transmembrane domain of a coronavirus E1 glycoprotein is required for its retention in the Golgi region. J. Cell Biol. 1987;105:1205–1214. doi: 10.1083/jcb.105.3.1205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Machamer C.E., Mentone S.A., Rose J.K., Farquhar M.G. The E1 glycoprotein of an avian coronavirus is targeted to the Golgi complex. Proc. Natl. Acad. Sci. USA. 1990;87:6944–6948. doi: 10.1073/pnas.87.18.6944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mackett M., Smith G.L., Moss B. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J. Virol. 1984;49:857–864. doi: 10.1128/jvi.49.3.857-864.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Moss B. Vaccinia virus: A tool for research and vaccine development. Science. 1991;252:1662–1667. doi: 10.1126/science.2047875. [DOI] [PubMed] [Google Scholar]
  14. Moss B. Poxvirus expression vectors. Curr. Top. Microbiol. Immunol. 1992;158:25–38. doi: 10.1007/978-3-642-75608-5_2. [DOI] [PubMed] [Google Scholar]
  15. Moss B., Elroy-Stein O., Mizukami T., Alexander W.A., Fuerst T.R. New mammalian expression vectors. Nature (London) 1990;348:91–92. doi: 10.1038/348091a0. [DOI] [PubMed] [Google Scholar]
  16. Schmelz M., Sodeik B., Ericsson M., Wolffe E., Shida H., Hiller G., Griffiths G. Assembly of vaccinia virus: The second wrapping cisterna is derived from the trans Golgi network. J. Virol. 1994;68:130–147. doi: 10.1128/jvi.68.1.130-147.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sodeik B., Doms R.W., Ericsson M., Hiller G., Machamer C.E., van't Hoff W., Van Meer G., Moss B., Griffiths G. Assembly of vaccinia virus: Role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks. J. Cell Biol. 1993;121:521–541. doi: 10.1083/jcb.121.3.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Spehner D., Gillard S., Drillien R., Kirn A. A cowpox virus gene required for multiplication in Chinese hamster ovary cells. J. Virol. 1988;62:1297–1304. doi: 10.1128/jvi.62.4.1297-1304.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wenzel R.P., Nettleman M.D. Smallpox vaccination for investigators using vaccinia recombinants. Lancet. 1989;ii:630–631. doi: 10.1016/s0140-6736(89)90760-5. [DOI] [PubMed] [Google Scholar]
  20. Yuen L., Moss B. Oligonucleotide sequence signaling transcriptional termination of vaccinia virus early genes. Proc. Natl. Acad. Sci. USA. 1987;84:6417–6421. doi: 10.1073/pnas.84.18.6417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Zagouras P., Ruusala A., Rose J.K. Dissociation and reassociation of oligomeric viral glycoprotein subunits in the endoplasmic reticulum. J. Virol. 1991;65:1976–1984. doi: 10.1128/jvi.65.4.1976-1984.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Methods in Cell Biology are provided here courtesy of Elsevier

RESOURCES